ACCESSION: MSBNK-SMB_Measured-HSA001P0183002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 120
COMMENT: RAW_SPEC {'BLK01_887': {'bp': 1318158.0, 'sum': 3575344.0}, 'BLK01_827': {'bp': 1210094.0, 'sum': 3074424.0}, 'BLK01_968': {'bp': 1177749.0, 'sum': 3425969.0}, 'BLK01_765': {'bp': 1073158.0, 'sum': 2532129.0}, 'BLK01_574': {'bp': 1008128.0, 'sum': 2729794.0}, 'BLK01_699': {'bp': 910091.0, 'sum': 2696613.0}, 'BLK01_1283': {'bp': 904528.0, 'sum': 2533103.0}, 'BLK01_1031': {'bp': 900474.0, 'sum': 2815602.0}, 'BLK01_638': {'bp': 887099.0, 'sum': 2500399.0}, 'BLK01_1095': {'bp': 812044.0, 'sum': 2452288.0}, '3_posi_733': {'bp': 534923.0, 'sum': 1846601.0}, 'BLK02_858': {'bp': 447548.0, 'sum': 1295682.0}, '17_posi_887': {'bp': 417365.0, 'sum': 1212709.0}, '12_posi_902': {'bp': 413454.0, 'sum': 1244506.0}, 'BLK02_1203': {'bp': 399461.0, 'sum': 1247594.0}, '8_posi_952': {'bp': 395592.0, 'sum': 1219387.0}, '3_posi_968': {'bp': 387649.0, 'sum': 1199983.0}, '10_posi_927': {'bp': 386820.0, 'sum': 1186315.0}, 'ProcedureBlank_888': {'bp': 384889.0, 'sum': 1099348.0}, 'BLK02_1055': {'bp': 382514.0, 'sum': 1257775.0}, '3_posi_1031': {'bp': 381476.0, 'sum': 1172784.0}, '7_posi_1080': {'bp': 380728.0, 'sum': 1133274.0}, '2_posi_921': {'bp': 371752.0, 'sum': 1165752.0}, '6_posi_897': {'bp': 369082.0, 'sum': 1100176.0}, '16_posi_907': {'bp': 366962.0, 'sum': 1121573.0}, '19_posi_865': {'bp': 365789.0, 'sum': 1007032.0}, '10_posi_1117': {'bp': 364237.0, 'sum': 1179684.0}, '7_posi_1017': {'bp': 361251.0, 'sum': 1131130.0}, '12_posi_1014': {'bp': 358520.0, 'sum': 1112669.0}, '2_posi_992': {'bp': 358437.0, 'sum': 1157550.0}, '9_posi_928': {'bp': 355708.0, 'sum': 1109034.0}, 'BLK02_1266': {'bp': 355466.0, 'sum': 1128322.0}, 'BLK02_992': {'bp': 355111.0, 'sum': 1159725.0}, '13_posi_881': {'bp': 353589.0, 'sum': 1034046.0}, '5_posi_923': {'bp': 353490.0, 'sum': 1096843.0}, '15_posi_909': {'bp': 353211.0, 'sum': 1094481.0}, '3_posi_1119': {'bp': 351487.0, 'sum': 1104297.0}, '6_posi_994': {'bp': 344512.0, 'sum': 1074016.0}, '12_posi_1140': {'bp': 339060.0, 'sum': 1052964.0}, 'ProcedureBlank_1223': {'bp': 337549.0, 'sum': 1086521.0}, '13_posi_950': {'bp': 337423.0, 'sum': 1024178.0}, '8_posi_1016': {'bp': 336682.0, 'sum': 1042566.0}, '9_posi_1119': {'bp': 335431.0, 'sum': 1071324.0}, '4_posi_1158': {'bp': 333683.0, 'sum': 1057446.0}, '6_posi_1181': {'bp': 333416.0, 'sum': 959838.0}, '4_posi_1095': {'bp': 333096.0, 'sum': 1077151.0}, '6_posi_1119': {'bp': 332871.0, 'sum': 1025882.0}, '11_posi_1035': {'bp': 332065.0, 'sum': 1030807.0}, '14_posi_1140': {'bp': 331770.0, 'sum': 1013612.0}, 'ProcedureBlank_1157': {'bp': 330184.0, 'sum': 1060275.0}, '9_posi_991': {'bp': 330026.0, 'sum': 1044085.0}, '11_posi_923': {'bp': 328940.0, 'sum': 1105901.0}, '16_posi_1031': {'bp': 328624.0, 'sum': 1007952.0}, '10_posi_1052': {'bp': 328197.0, 'sum': 1026831.0}, '9_posi_1181': {'bp': 326093.0, 'sum': 1051657.0}, '1_posi_1242': {'bp': 325152.0, 'sum': 1065272.0}, '12_posi_1204': {'bp': 324176.0, 'sum': 1016366.0}, '7_posi_952': {'bp': 322253.0, 'sum': 1038239.0}, '17_posi_991': {'bp': 321546.0, 'sum': 1001760.0}, '10_posi_1202': {'bp': 320097.0, 'sum': 998839.0}, '5_posi_1140': {'bp': 319841.0, 'sum': 1026437.0}, '14_posi_990': {'bp': 319063.0, 'sum': 949191.0}, '17_posi_1202': {'bp': 318668.0, 'sum': 997625.0}, '5_posi_1202': {'bp': 318312.0, 'sum': 989797.0}, '13_posi_1015': {'bp': 316570.0, 'sum': 1009159.0}, '1_posi_1179': {'bp': 316204.0, 'sum': 1024179.0}, '9_posi_1055': {'bp': 314333.0, 'sum': 1051020.0}, '5_posi_989': {'bp': 308729.0, 'sum': 988635.0}, '8_posi_1079': {'bp': 308215.0, 'sum': 1037069.0}, '13_posi_1160': {'bp': 307858.0, 'sum': 968889.0}, '18_posi_1142': {'bp': 305832.0, 'sum': 972752.0}, '18_posi_1078': {'bp': 304607.0, 'sum': 933923.0}, '3_posi_1242': {'bp': 304429.0, 'sum': 973136.0}, '11_posi_1097': {'bp': 303041.0, 'sum': 974080.0}, '8_posi_1203': {'bp': 302994.0, 'sum': 962347.0}, '15_posi_1035': {'bp': 302796.0, 'sum': 966382.0}, '16_posi_968': {'bp': 302256.0, 'sum': 946505.0}, '13_posi_1286': {'bp': 302027.0, 'sum': 953016.0}, '17_posi_1053': {'bp': 301880.0, 'sum': 991584.0}, '17_posi_1114': {'bp': 300896.0, 'sum': 988254.0}, '14_posi_1077': {'bp': 300622.0, 'sum': 997760.0}, '2_posi_1307': {'bp': 300537.0, 'sum': 993552.0}, '13_posi_1222': {'bp': 300452.0, 'sum': 990850.0}, '15_posi_1242': {'bp': 299760.0, 'sum': 978148.0}, '2_posi_1244': {'bp': 298178.0, 'sum': 945286.0}, '13_posi_1077': {'bp': 295120.0, 'sum': 945856.0}, '19_posi_925': {'bp': 295016.0, 'sum': 910019.0}, '10_posi_1265': {'bp': 294852.0, 'sum': 1013772.0}, '9_posi_1246': {'bp': 292575.0, 'sum': 949103.0}, '18_posi_953': {'bp': 290953.0, 'sum': 933393.0}, '16_posi_1241': {'bp': 288626.0, 'sum': 962869.0}, '11_posi_1160': {'bp': 286239.0, 'sum': 931729.0}, '6_posi_1267': {'bp': 286131.0, 'sum': 953706.0}, '7_posi_1244': {'bp': 284787.0, 'sum': 881315.0}, '17_posi_1265': {'bp': 283053.0, 'sum': 931572.0}, '11_posi_1221': {'bp': 277696.0, 'sum': 914774.0}, '14_posi_1244': {'bp': 277295.0, 'sum': 956803.0}, '18_posi_638': {'bp': 274648.0, 'sum': 915554.0}, 'ProcedureBlank_1306': {'bp': 273972.0, 'sum': 901396.0}, '15_posi_1097': {'bp': 267696.0, 'sum': 854859.0}, '5_posi_1265': {'bp': 267448.0, 'sum': 881507.0}, '7_posi_1308': {'bp': 267359.0, 'sum': 840580.0}, '19_posi_990': {'bp': 264798.0, 'sum': 885879.0}, '8_posi_1285': {'bp': 262786.0, 'sum': 851980.0}, '12_posi_1266': {'bp': 258170.0, 'sum': 884505.0}, '9_posi_1307': {'bp': 255543.0, 'sum': 831771.0}, '11_posi_1284': {'bp': 255044.0, 'sum': 907840.0}, '4_posi_1288': {'bp': 254513.0, 'sum': 830831.0}, '19_posi_1118': {'bp': 248051.0, 'sum': 821375.0}, '14_posi_1306': {'bp': 246946.0, 'sum': 806437.0}, '19_posi_1182': {'bp': 243490.0, 'sum': 812752.0}, '18_posi_1016': {'bp': 241092.0, 'sum': 837253.0}, '19_posi_579': {'bp': 236700.0, 'sum': 830337.0}, '18_posi_1203': {'bp': 235983.0, 'sum': 776854.0}, '16_posi_1304': {'bp': 233053.0, 'sum': 784712.0}, '19_posi_1244': {'bp': 230797.0, 'sum': 741342.0}, '18_posi_1266': {'bp': 230093.0, 'sum': 741419.0}, '15_posi_1307': {'bp': 227253.0, 'sum': 735816.0}, '19_posi_1055': {'bp': 222927.0, 'sum': 699246.0}, '19_posi_1309': {'bp': 204361.0, 'sum': 696137.0}}
COMMENT: RETENTION_TIME_STDEV 0.339
COMMENT: PRECURSOR_M/Z_RAW 183.123734
COMMENT: PRECURSOR_M/Z_STDEV 0.000049
COMMENT: PRECURSOR_IN_MS1 mz 183.124063; int 135.193; delta(ppm) 1.123191
COMMENT: PROPOSED_CHARGE_STATE +1; mz 184.127292; int 10.718; cor 0.772
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 215.150307; int 24.262; cor 0.788
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 224.150597; int 18.695; cor 0.818
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 224.150597; int 18.695; cor 0.818
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 224.150597; int 18.695; cor 0.818
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+NH4; mz 118.097433; int 4.211; cor 0.707
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.055; C8H14N4O; [M+H]+; delta(ppm) 0.054910
COMMENT: PROPOSED_MF SevenGoldenRules 0.085; C6H11N3O; [M+ACN+H]+; delta(ppm) 0.085052
COMMENT: PROPOSED_MF SevenGoldenRules 0.140; C4H8N2O; [M+2ACN+H]+; delta(ppm) 0.139911
COMMENT: PROPOSED_MF MS-FINDER 3.368; C6H11N3O; [M+ACN+H]+; delta(ppm) 89372.006542
COMMENT: PROPOSED_MF MS-FINDER 3.303; C8H14N4O; [M+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF MS-FINDER 3.214; C4H8N2O; [M+2ACN+H]+; delta(ppm) 441081.793195
COMMENT: PROPOSED_MF SIRIUS5_Sirius 42.869; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS5_Sirius 42.869; C8H14N4O; [M+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS5_Sirius 34.923; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N4O; [M+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS6_Sirius 74.996; C8H14N4O; [M+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS6_Sirius 74.996; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS6_Sirius 74.996; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS6_Sirius 68.334; C5H15FN4O2; [M+H]+; delta(ppm) -6.188029
COMMENT: PROPOSED_MF SIRIUS6_Sirius 46.295; C8H18NO2; [M+Na]+; delta(ppm) 51613.413394
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.094; C4H17N5OP; [M+H]+; delta(ppm) -1.636228
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.631; C10H16NO2; [M+H]+; delta(ppm) -7.280224
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.631; C8H13O2; [M+C2H3N+H]+; delta(ppm) -7.280224
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.354; C6H12N7; [M+H]+; delta(ppm) 7.383757
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.354; C2H6N5; [M+C4H6N2+H]+; delta(ppm) 7.383757
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.354; C4H9N6; [M+C2H3N+H]+; delta(ppm) 7.383757
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.441; C8H15F3N; [M+H]+; delta(ppm) 6.072872
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.380; C2H15N8P; [M+H]+; delta(ppm) 5.695791
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N4O; [M+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H18NO2; [M+Na]+; delta(ppm) 51613.413394
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.051713
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.818; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; NC(CCC1=CN=CN1)CC(O)=N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.586; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; CCCC1=NN(C)C(C(N)=O)=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.522; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; N=1OC(=NC1C)C2N(C)CC(N)C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.505; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; NCCC(=O)NCCC1=CN=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.253; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; CC(C)(C)C1=CC(=NN1)C(=O)NN
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.727; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.501; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.269; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; CNP0438350
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.232; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+2ACN+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.221; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-1-methyl-3-propylpyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.189; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; 3-amino-5-(1H-imidazol-5-yl)pentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.097; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.047; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.028; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.909; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.993; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.913; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+2ACN+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.841; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; 3-amino-5-(1H-imidazol-5-yl)pentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.772; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; CNP0438350
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.659; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-1-methyl-3-propylpyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.390; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.094; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.909; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; (2S)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.100; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; 1-nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.969; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.764; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; 1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.590; IMAGWKUTFZRWSB-HWKANZROSA-N; [M+2ACN+H]+; N-[(E)-ethylideneamino]-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.370; DWEQVNFWAKJCEY-UHFFFAOYSA-N; [M+2ACN+H]+; 4-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.329; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-5-propylpyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.259; SINFFOPRQUJXEU-UHFFFAOYSA-N; [M+H]+; [1-(oxan-4-yl)pyrazol-3-yl]hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.204; OXTSWTYFSHETKF-UHFFFAOYSA-N; [M+H]+; 4-amino-N,2-diethylpyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; NMGPZPUIAUQPJA-UHFFFAOYSA-N; [M+ACN+H]+; [1-(2-aminoethyl)imidazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.148; OZVXTNDTEWDMGH-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-2-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; IBYIOHMUWBIKCY-UHFFFAOYSA-N; [M+2ACN+H]+; N-methoxyazetidin-3-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.140; QKHNQZUVFSQKFD-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.138; USQBXXFEWJNNLW-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-piperidin-4-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.134; VCPRZYKEIPMTGJ-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-2-(1-methylpyrazol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; GTEXXCCAHDQARI-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-pyrazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; OZGHNDLEHPCVJQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-[4-(aminomethyl)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; IPLIJMUJLJBZDZ-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-imidazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.116; CIECLHRLHFXCEF-UHFFFAOYSA-N; [M+H]+; 6-ethyl-4-(propan-2-ylamino)-1H-1,3,5-triazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.115; OTXQUUARRHAWEI-UHFFFAOYSA-N; [M+H]+; 5-(1-methylpiperidin-3-yl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.109; QEHBKIRYKVJAAQ-UHFFFAOYSA-N; [M+H]+; (1-piperidin-3-yltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.106; NPNNXLZXOYJJIV-UHFFFAOYSA-N; [M+H]+; [1-(oxan-4-yl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.096; APLFLTVZOUDTFG-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-(oxan-4-yl)-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; AJOFBNLXIBLIPM-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(1-methylimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; KMUNXDCQPABTSC-UHFFFAOYSA-N; [M+H]+; N,4-diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; FSRLLJVJCVKHQI-UHFFFAOYSA-N; [M+2ACN+H]+; 2-amino-3-hydroxy-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.072; RUOBZLJWEMZMRP-UHFFFAOYSA-N; [M+H]+; 2-(5-ethyl-1H-1,2,4-triazol-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; IADZORFSCHBHIT-UHFFFAOYSA-N; [M+H]+; 3-methyl-4-(piperazin-1-ylmethyl)-1,2,5-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.065; NTVMXTHTWWIQBG-RNFRBKRXSA-N; [M+H]+; [(2R,3R)-2-(3-methyl-1H-1,2,4-triazol-5-yl)oxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; AFGWGIRVJYUUMY-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; ZIWIZUNXJJKHPT-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)piperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.051; JLNGHOSDXPAGAH-UHFFFAOYSA-N; [M+H]+; 4-(2-methyl-1,2,4-triazol-3-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; RYFSOJLJCKEYBP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1-aminoethyl)-1-methylpyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; AKKYYGMQUOASSM-UHFFFAOYSA-N; [M+H]+; 5-methyl-N'-propan-2-yl-3H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.028; VQXSKHZPJBCSIZ-UHFFFAOYSA-N; [M+H]+; [3-(oxan-4-yl)-1H-1,2,4-triazol-5-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; OCEJLBIKKZYCBH-UHFFFAOYSA-N; [M+ACN+H]+; 1-(azetidin-3-yl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.022; ASEMWMLOGSUFFL-UHFFFAOYSA-N; [M+ACN+H]+; 4-(2-aminoethyl)-3-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.011; IVIGOAVSYQZAMR-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; YHUCZYONIXCWBX-VQVTYTSYSA-N; [M+H]+; (1S,2S,4R)-2-(aminomethyl)-4-(1H-1,2,4-triazol-5-yl)cyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.004; RTGLANPQFMENLF-UHFFFAOYSA-N; [M+ACN+H]+; 2,5,6,7,8,8a-hexahydro-1H-imidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; ZQIOGDSNYJYBTN-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-aminopyrazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; DZQDVYLUCQEKGH-UHFFFAOYSA-N; [M+H]+; 4-methoxy-N-methyl-6-propyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; VEBSQSGLZKTWDS-BQBZGAKWSA-N; [M+H]+; N-methyl-1-[(2R,3R)-3-(1H-1,2,4-triazol-5-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; HKUSMMLJSPSXCL-UHFFFAOYSA-N; [M+ACN+H]+; 5-(3-aminopropyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; QJCMYUTUCCCBMY-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-aminopyrazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; AMRWCMHXSOIYPO-UHFFFAOYSA-N; [M+H]+; (5-piperidin-1-yl-1,3,4-oxadiazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; DJPLUEGVLBIDTL-UHFFFAOYSA-N; [M+H]+; 4-[2-(dimethylamino)ethoxy]pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.992; YNDAMDVOGKACTP-UHFFFAOYSA-N; [M+2ACN+H]+; 3-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.989; IUBWCBLFKCGVGV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(2-iminopyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; YUTDFIMDLUJOJK-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; GNMSTEOVIGIVCR-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydrotriazolo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; VCSSOKBEBXXSDV-UHFFFAOYSA-N; [M+ACN+H]+; 5-methyl-2,5,7-triazaspiro[3.4]octan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; JIMSBKAHGYGPLD-UHFFFAOYSA-N; [M+2ACN+H]+; 4-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; LGPFTDILVKZMRC-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-amino-4-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.931; YXAYZDNOWMFZLL-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(3-methyldiazirin-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.930; DHXLEVPVBKFTTR-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-pyrrolidin-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; YCXQDZIPLMEYGK-UHFFFAOYSA-N; [M+ACN+H]+; 2-[4-(methylamino)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.921; QYLRWTDPRQLHNV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methyldiazirin-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; RPGPPCHMKDWLRT-UHFFFAOYSA-N; [M+2ACN+H]+; 2-amino-3-methoxypropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.915; YSSJLUSRTMOENN-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; MHFBJJKCSNFJEO-UHFFFAOYSA-N; [M+2ACN+H]+; 4,5-dihydro-1,2-oxazol-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; JTPZTKBRUCILQD-UHFFFAOYSA-N; [M+2ACN+H]+; 1-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; WRNALNJFNAAVKM-UHFFFAOYSA-N; [M+ACN+H]+; 2,5,7-triazaspiro[3.5]nonan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; QSRIMEJLSVTOCT-UHFFFAOYSA-N; [M+H]+; 4-[2-(1,2,4-triazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; NDFXVDCXWFVBHJ-UHFFFAOYSA-N; [M+H]+; 5-amino-1-tert-butylpyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; UAUSQEVPWPGBHG-UHFFFAOYSA-N; [M+2ACN+H]+; 3-aminobut-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.886; VPJDULFXCAQHRC-UHFFFAOYSA-N; [M+2ACN+H]+; prop-2-enylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.859; ITDOBWWRWYKLQJ-UHFFFAOYSA-N; [M+ACN+H]+; 2,3,4,5-tetrahydropyridin-6-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; LHHBJUDYVRBYMB-UHFFFAOYSA-N; [M+ACN+H]+; 4-(aminomethyl)-2,5-dimethyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.840; ANQYOZSPKNDFPD-UHFFFAOYSA-N; [M+ACN+H]+; 2-(5-amino-3-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.827; YGJWTXRSKNXUAY-UHFFFAOYSA-N; [M+ACN+H]+; 5-methoxy-1,3-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; JKZWEWZMYSBQME-UHFFFAOYSA-N; [M+2ACN+H]+; 1-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; KENWBTPXOITUBG-UHFFFAOYSA-N; [M+ACN+H]+; 3-(5-methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; XIAOMTCYUPNRKB-UHFFFAOYSA-N; [M+ACN+H]+; (2-propan-2-yl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; ZPUGMHPXVOHOAZ-UHFFFAOYSA-N; [M+ACN+H]+; (4-propyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; YEKKCMQUYOKDQD-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-methyl-1,2,4-oxadiazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; WBHVOQXHRCGQTP-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-ethyl-1,2,4-oxadiazol-5-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.815; LURMHCWOXHNATM-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; CIZWSGSWDKEWQD-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methoxyethyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.804; AEBOLOPWWMZLBL-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methyl-1,2,4-oxadiazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.804; KJTMKVRSTYLHQN-UHFFFAOYSA-N; [M+ACN+H]+; 5-(methoxymethyl)-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; VQNRBFXKOWOEAC-UHFFFAOYSA-N; [M+ACN+H]+; 3-ethoxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; WWGWIEDOVSRZPU-UHFFFAOYSA-N; [M+ACN+H]+; 2-tert-butyl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; REYGCAPKUGCICS-UHFFFAOYSA-N; [M+ACN+H]+; N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; JANUDBLANRHSLI-UHFFFAOYSA-N; [M+ACN+H]+; 5-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; XWBPAFFFOLTPTR-UHFFFAOYSA-N; [M+ACN+H]+; 3-(methoxymethyl)-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; MGDACALOFCAYGF-UHFFFAOYSA-N; [M+ACN+H]+; (3-methoxy-1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.758; WYVJDRGXWOXCCH-UHFFFAOYSA-N; [M+2ACN+H]+; 5-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.755; VUQAASCCQZTWOG-UHFFFAOYSA-N; [M+ACN+H]+; 5-butan-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.751; SRIBOFCAJXTSEL-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.740; IZYJJPFDVHGKAG-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.735; UXZYNPKVFMWVMT-UHFFFAOYSA-N; [M+ACN+H]+; 1-ethyl-3-methoxypyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.734; WONCYNYJYMAVNA-UHFFFAOYSA-N; [M+ACN+H]+; 5-tert-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.732; ILUUSWWGUOPVLO-UHFFFAOYSA-N; [M+ACN+H]+; 3-tert-butyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.731; VPOYXTRLFXNRJN-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-3-propan-2-yl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.729; WJYMBVJBSFMDLE-HWKANZROSA-N; [M+2ACN+H]+; (2E)-2-(dimethylhydrazinylidene)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.727; PEPBWGGISBCQDW-UHFFFAOYSA-N; [M+ACN+H]+; (3-propan-2-yl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.727; XGPRUICIGLRGSQ-UHFFFAOYSA-N; [M+ACN+H]+; (5-propan-2-yl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.726; VAYGOKAONCMZCM-UHFFFAOYSA-N; [M+ACN+H]+; 5-tert-butyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.726; KGTZRGLLNSCJNH-UHFFFAOYSA-N; [M+ACN+H]+; 5-(2-methylpropyl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.633; YNDAMDVOGKACTP; [M+C4H6N2+H]+; Ambcb4019954
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -127.660; IMAGWKUTFZRWSB; [M+C4H6N2+H]+; Ethylidene gyromitrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.282; IWELDVXSEVIIGI; [M+C4H6N2+H]+; piperazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.451; WJYMBVJBSFMDLE; [M+C4H6N2+H]+; Glyoxal mono-dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.383; DWEQVNFWAKJCEY; [M+C4H6N2+H]+; 4-Methyl-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.684; JTPZTKBRUCILQD; [M+C4H6N2+H]+; 1-Methyl-2-imidazolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.922; KENWBTPXOITUBG; [M+C2H3N+H]+; [3-(5-methyl-1,3,4-oxadiazol-2-yl)propyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -148.547; PZMXDLWWQHYXGY; [M+H]+; Oprea1_583437
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.206; QIXFXNMDRJRTIJ; [M+C2H3N+H]+; 1-Hem-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.300; NQPJDJVGBDHCAD; [M+C4H6N2+H]+; Propyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.557; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.405; UAUSQEVPWPGBHG; [M+C4H6N2+H]+; 3-Aminocrotonamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.440; WNYADZVDBIBLJJ; [M+C4H6N2+H]+; Nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.840; IPLIJMUJLJBZDZ; [M+C2H3N+H]+; 3-amino-1-imidazolylpropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.414; KKCWBKUOPJMUQV; [M+C4H6N2+H]+; 2-azetidinecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.657; CIZWSGSWDKEWQD; [M+C2H3N+H]+; 1-(2-methoxyethyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.588; ZQISRDCJNBUVMM; [M+C2H3N+H]+; histidol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.586; VPQRCGYRFWYOEO; [M+C4H6N2+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.440; KAXILSKFDQXZPP; [M+C4H6N2+H]+; Vinylethylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -195.184; DUCOZVHXTHIRIB; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.092; OWSNZTOUPZXKPJ; [M+C4H6N2+H]+; Methylallylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.267; VPJDULFXCAQHRC; [M+C4H6N2+H]+; Allylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.763; AWDNCVJVQYZMTL; [M+C4H6N2+H]+; N-Methylethyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.292; CNQSLMMJABEBDE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.827; LURMHCWOXHNATM; [M+C2H3N+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.496; JFYKIEHOOZWARC; [M+C4H6N2+H]+; Oprea1_824763
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.402; OMCUPXRCMTUDHI; [M+C4H6N2+H]+; Cyclopropanecarboxamidoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.108; WONCYNYJYMAVNA; [M+C2H3N+H]+; 2-Amino-5-tert-butyl-1,3,4-oxadiazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.303; AFGWGIRVJYUUMY; [M+H]+; Ambcb5109422
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.374; KMUNXDCQPABTSC; [M+H]+; N,4-Diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.861; CLMGCKCDSPUQEE; [M+C4H6N2+H]+; cyclopropylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.163; YDDAGKSURVEMCI; [M+C2H3N+H]+; Acetamide, 2-diazo-N,N-diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.971; DZOWYKFQSIAYCW; [M+C4H6N2+H]+; 3,6-dihydro-2H-oxazin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.835; UEUMMYRZUZKMRI; [M+C2H3N+H]+; Ambap52883-26-8
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.672; DHXLEVPVBKFTTR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.806; NDFXVDCXWFVBHJ; [M+H]+; 5-amino-1-tert-butylpyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.255; CIECLHRLHFXCEF; [M+H]+; 2-ethyl-6-(propan-2-ylamino)-1H-1,3,5-triazin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.978; DZQDVYLUCQEKGH; [M+H]+; 4-Methoxy-N-methyl-6-propyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.691; ITDOBWWRWYKLQJ; [M+C2H3N+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.324; IVIGOAVSYQZAMR; [M+H]+; 4-Ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.572; YXAYZDNOWMFZLL; [M+C4H6N2+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.294; ZJULPBMTEMGRNC; [M+C4H6N2+H]+; 2-Methoxyimidazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.915; YUTDFIMDLUJOJK; [M+C2H3N+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.365; PIXPFRMNXPKTFS; [M+C4H6N2+H]+; 4-Methyl-oxazolidin-(2Z)-ylideneamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.705; QSRIMEJLSVTOCT; [M+H]+; 4-[2-(1,2,4-triazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.007; ZHFKVNRMZIOKGZ; [M+C4H6N2+H]+; 2-Oxazolamine, 4,5-dihydro-5-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -287.768; DJPLUEGVLBIDTL; [M+H]+; 2-Amino-4-dimethylaminoethoxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.389; APLFLTVZOUDTFG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -301.938; MIWXKXSYVQATIB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -419.098; AKKYYGMQUOASSM; [M+H]+; 1-(5-Methyl-3-pyrazolylcarbonyl)-2-isopropylhydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.326; PZMXDLWWQHYXGY; [M+H]+; Oprea1_583437
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.247; KENWBTPXOITUBG; [M+C2H3N+H]+; [3-(5-methyl-1,3,4-oxadiazol-2-yl)propyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.188; YNDAMDVOGKACTP; [M+C4H6N2+H]+; Ambcb4019954
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -62.263; UAUSQEVPWPGBHG; [M+C4H6N2+H]+; (Z)-3-aminobut-2-enimidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.317; IWELDVXSEVIIGI; [M+C4H6N2+H]+; 1,3,3,4,5,5-Hexadeuteriopiperazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.190; KAYNYFQEUPJJMT; [M+Na]+; [[tert-Butyl(tert-butoxy)amino]oxy]radical
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.864; IMAGWKUTFZRWSB; [M+C4H6N2+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -111.116; WJYMBVJBSFMDLE; [M+C4H6N2+H]+; Glyoxal dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.827; KAXILSKFDQXZPP; [M+C4H6N2+H]+; Vinylethylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.554; CWTDBXBAFSXFET; [M+C4H6N2+H]+; 3-Methylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.141; DZOWYKFQSIAYCW; [M+C4H6N2+H]+; 3,6-dihydro-2H-oxazin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.556; OWSNZTOUPZXKPJ; [M+C4H6N2+H]+; N-Nitroso-N-methylallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.605; NETSEJKXZLQGHX; [M+Na]+; [[1-(Butylamino)butyl]peroxy]radical
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -133.617; VPQRCGYRFWYOEO; [M+C4H6N2+H]+; 3-Methylaziridine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -141.008; MFCHWYSOGVAXNC; [M+C4H6N2+H]+; N-methyl-N-(nitrosomethyl)ethenamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.738; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -160.447; OZVXTNDTEWDMGH; [M+C2H3N+H]+; 2-amino-2-(1-methyl-1H-pyrazol-4-yl)ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.305; HAUMDMJMVPAREL; [M+Na]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -164.705; YDDAGKSURVEMCI; [M+C2H3N+H]+; (E)-2-(diethylamino)-2-hydroxyethenediazonium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -165.350; REYGCAPKUGCICS; [M+C2H3N+H]+; N-[(3-Methyl-1,2,4-oxadiazol-5-YL)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -166.231; KMUNXDCQPABTSC; [M+H]+; N,4-Diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -181.731; QSRIMEJLSVTOCT; [M+H]+; 4-(2-(1H-1,2,4-Triazol-1-yl)ethyl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -185.793; NDFXVDCXWFVBHJ; [M+H]+; 5-amino-1-tert-butyl-1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.753; QIXFXNMDRJRTIJ; [M+C2H3N+H]+; 1-(2-Hydroxyethyl)-2-methyl-5-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.926; GNMSTEOVIGIVCR; [M+H]+; 1-(2-methoxyethyl)-1H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.537; KENWBTPXOITUBG; [M+C2H3N+H]+; 3-(5-Methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.848; CIECLHRLHFXCEF; [M+H]+; 1,3,5-Triazin-2(1H)-one, 4-ethyl-6-((1-methylethyl)amino)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.876; QKHNQZUVFSQKFD; [M+C2H3N+H]+; (1R)-2-Amino-1-(1-methyl-1H-pyrazol-4-yl)ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -198.510; AFGWGIRVJYUUMY; [M+H]+; 4-Ethoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.244; YSSJLUSRTMOENN; [M+H]+; 2-(methoxymethyl)-5H,6H,7H,8H-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.397; UEUMMYRZUZKMRI; [M+C2H3N+H]+; 4,5-Diethyl-2,4-dihydro-3H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -204.977; XIAOMTCYUPNRKB; [M+C2H3N+H]+; [1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]methanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -206.602; JMPBEKGLEKWBNL; [M+Na]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -214.119; LEWKFFUYRKWKLV; [M+C2H3N+H]+; 2-Isopropyl-5-methyl-2,4-dihydro-[1,2,4]triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -214.722; ANQYOZSPKNDFPD; [M+C2H3N+H]+; 2-(5-amino-3-methyl-1H-pyrazol-1-yl)ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.611; AKKYYGMQUOASSM; [M+H]+; 1-(5-Methyl-3-pyrazolylcarbonyl)-2-isopropylhydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.964; DZQDVYLUCQEKGH; [M+H]+; 1,3,5-Triazin-2-amine, 4-methoxy-N-methyl-6-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.281; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.189; UAUSQEVPWPGBHG; [M+C4H6N2+H]+; (Z)-3-aminobut-2-enimidate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.068; OZVXTNDTEWDMGH; [M+C2H3N+H]+; 2-amino-2-(1-methyl-1H-pyrazol-4-yl)ethan-1-ol
COMMENT: CONFIDENCE Level 5: Exact mass of interest 183.124047; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 2.168
MS$FOCUSED_ION: PRECURSOR_M/Z 183.124047
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-1900000000-9583ae671f7192ad1804
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  69.0447044 52.6771 ? 69.045330 1.3759 14.20 0.3075 120
  71.0603168 50.4227 ? 71.060930 1.4073 8.96 0.6405 120
  72.0444035 107.2880 ? 72.045010 0.6385 15.61 0.6912 120
  85.0759508 28.8525 ? 85.076430 1.2695 6.97 0.7015 120
  87.0915869 29.3461 ? 87.092040 1.3090 7.56 0.4937 119
  98.9841100 34.8157 ? 98.984440 1.2224 12.31 -0.1161 120
  112.0868654 39.9413 ? 112.087070 1.2223 10.02 0.5501 120
  113.0709664 281.9293 ? 113.071160 0.3714 41.12 0.9229 120
  115.0502092 25.0196 ? 115.050380 1.7210 8.27 0.1486 117
  115.0866196 545.0709 ? 115.086790 0.3041 70.32 0.7986 120
  123.0553357 15.9473 ? 123.055405 2.4217 4.70 0.4884 86
  124.0869099 40.6976 ? 124.086965 1.3055 8.23 0.7108 120
  125.0709086 29.3815 ? 125.070950 1.6071 7.81 0.3383 120
  127.0154464 32.4690 ? 127.015460 1.3148 10.96 0.0314 119
  138.0661944 33.9011 ? 138.066100 1.5790 12.49 -0.1161 120
  138.1025545 27.3555 ? 138.102460 1.6872 6.98 0.5219 118
  140.0818657 96.4125 ? 140.081770 0.9066 15.68 0.8147 120
  142.0975371 21.3914 ? 142.097440 2.0268 7.41 0.0732 113
  155.0466154 17.9900 ? 155.046510 2.4960 7.05 -0.0271 105
  155.0926755 24.5530 ? 155.092570 1.9795 8.40 0.0324 116
  165.1135019 50.9863 ? 165.113390 1.5202 8.68 0.7975 120
  166.0975525 45.7562 ? 166.097440 1.5653 9.70 0.7053 120
  183.1241683 999.0000 ? 183.124045 0.3823 0.00 1.0000 120
  183.1600533 194.7611 ? 183.159930 1.1848 26.65 0.8638 113
  183.1942034 98.3159 ? 183.194080 1.3810 32.33 -0.1304 119
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  69.044704 52.68 52
  71.060317 50.42 50
  72.044403 107.29 107
  85.075951 28.85 28
  87.091587 29.35 29
  98.984110 34.82 34
  112.086865 39.94 39
  113.070966 281.93 281
  115.050209 25.02 25
  115.086620 545.07 545
  123.055336 15.95 15
  124.086910 40.70 40
  125.070909 29.38 29
  127.015446 32.47 32
  138.066194 33.90 33
  138.102554 27.36 27
  140.081866 96.41 96
  142.097537 21.39 21
  155.046615 17.99 17
  155.092675 24.55 24
  165.113502 50.99 50
  166.097553 45.76 45
  183.124168 999.00 999
  183.160053 194.76 194
  183.194203 98.32 98
//
